查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1539395

臨床前影像市場：2024-2031年全球產業分析、規模、佔有率、成長、趨勢、預測

Preclinical Imaging Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 170 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份關於全球臨床前影像市場的綜合報告。本報告對重要的市場動態進行了詳細評估，包括關鍵驅動因素、趨勢、機會和挑戰，並對市場結構提供了深入的見解。

關鍵見解

  • 臨床前影像市場規模（2024年）：43億美元
  • 預測市場規模（2031年）：59.6億美元
  • 全球市場成長率（2024-2031年年複合成長率）：4.55%

臨床前影像市場 - 報告範圍：

臨床前影像對於新藥和新療法的開發非常重要，它使研究人員能夠在早期階段可視化並了解干預措施的效果。臨床前影像市場包括各種影像技術，如 MRI、PET、CT 和光學影像系統。這些技術應用於各種研究環境，包括學術機構、製藥公司和合約研究組織（CRO），以支持藥物開發、疾病研究和治療功效研究。

研究中對先進成像技術的需求不斷成長、藥物發現投資的增加以及提高成像分辨率和精度的技術進步推動了市場成長。此外，慢性病的流行和個人化醫療需求的不斷成長進一步推動了市場的擴張。

推動市場成長的因素：

有幾個關鍵因素推動全球臨床前影像市場。影像技術的快速進步，例如高解析度 MRI 和 PET/CT 系統的集成，大幅提高了研究能力。製藥和生物技術公司對研發的投資不斷增加，推動了對先進成像解決方案的需求，以加速藥物開發進程。此外，慢性病的增加和個人化醫療的需求推動先進影像技術的採用，以實現準確的疾病建模和治療評估。

分子影像和多模態成像系統的開發等技術創新也促進了市場成長。這些創新提高了臨床前研究的精確度，能夠對生物過程進行更詳細的分析，並支持新療法和療法的進步。

市場限制因素：

儘管成長前景廣闊，但臨床前影像市場仍面臨一些挑戰。先進成像系統的高成本可能會限制其採用，特別是在發展中地區的小型研究機構或研發機構。此外，影像技術的複雜性和專業訓練的需要可能會對有效利用造成障礙。新成像技術的監管限制和漫長的審批流程也可能影響市場動態。

應對這些挑戰需要持續努力降低成本、加強用戶培訓並簡化監管途徑，以促進更廣泛地獲得先進成像解決方案。

市場機會：

由於技術進步和研究活動的增加，臨床前影像市場提供了巨大的成長機會。攜帶式、經濟高效的成像解決方案的開發以及人工智慧和機器學習資料分析的集成為市場擴張提供了新的途徑。此外，研究機構、技術開發商和製藥公司之間的合作預計將促進創新並加速先進成像技術的採用。

對個人化醫療和標靶治療的日益關注也增加了開發適合特定研究需求的專門影像處理系統的機會。策略合作夥伴關係、對尖端技術的投資以及向新興市場的擴張對於利用這些機會和維持市場成長非常重要。

本報告解決的關鍵問題

  • 推動全球臨床前影像市場成長的關鍵因素是什麼？
  • 哪些影像技術和應用在臨床前研究中受到關注？
  • 技術進步如何改變臨床前影像市場的競爭格局？
  • 誰是對臨床前影像市場做出貢獻的主要公司？
  • 全球臨床前影像市場的新趨勢和未來前景是什麼？

目錄

第1章 執行摘要

第2章 市場概述

  • 市場範圍與定義
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 課題
    • 主要趨勢
  • 臨床前影像市場：價值鏈
    • 主要參與者名單
    • 主要經銷商名單
  • 預測因子 - 相關性和影響
  • 新冠肺炎（COVID-19）影響評估
  • PESTLE分析
  • 波特五力分析

第3章 主要法規/標準

第4章 2019-2031年價格趨勢分析

  • 影響價格的主要因素
  • 價格：依來源

第5章 全球臨床前影像市場展望：實績（2019-2023年）與預測（2024-2031年）

  • 市場規模（十億美元）分析與預測
    • 過去的市場規模分析，2019-2023年
    • 目前市場規模預測，2024年至2031年
  • 全球臨床前影像市場展望：產品類型
    • 2019-2023年歷史市場規模（十億美元）分析，依產品類型
    • 2024-2031年目前市場規模（十億美元）預測，依產品類型
    • 市場吸引力分析：產品類型
  • 全球臨床前影像市場展望：應用
    • 2019-2023年過去的市場規模（十億美元）分析，依應用
    • 2024-2031年當前市場規模（十億美元）預測，依應用
    • 市場吸引力分析：應用
  • 全球臨床前影像市場展望：最終用戶
    • 2019-2023年歷史市場規模（十億美元）分析，依最終用戶
    • 2024-2031年目前市場規模（十億美元）預測，依最終用戶
    • 市場吸引力分析：最終用戶

第6章 全球臨床前影像市場展望：地區

  • 2019-2023年歷史市場規模（十億美元）分析，依地區
  • 2024-2031年當前市場規模（十億美元）預測，依地區
    • 北美
    • 歐洲
    • 東亞
    • 南亞/大洋洲
    • 拉丁美洲
    • 中東、非洲
  • 市場吸引力分析：地區

第7章 北美臨床前影像市場展望：實績（2019-2023年）與預測（2024-2031年）

第8章 歐洲臨床前影像市場展望：實績（2019-2023年）與預測（2024-2031年）

第9章 東亞臨床前影像市場展望：實績（2019-2023年）與預測（2024-2031年）

第10章 南亞/大洋洲臨床前影像市場展望：實績（2019-2023年）與預測（2024-2031年）

第11章 拉丁美洲臨床前影像市場展望：實績（2019-2023年）與預測（2024-2031年）

第12章 中東和非洲的臨床前影像展望：實績（2019-2023年）和預測（2024-2031年）

第13章 競爭態勢

  • 2024年市佔率分析
  • 市場結構
    • 競爭強度圖：依市場劃分
    • 競爭儀表板
    • 層次結構分析
    • 區域分佈分析
  • 公司簡介（詳細資料 - 概述、財務狀況、策略、近期發展）
    • Bruker Corporation
    • Siemens AG
    • General Electric（GE）
    • TriFoil Imaging
    • PerkinElmer, Inc.
    • VisualSonics Inc.（Fujifilm）
    • Mediso Ltd.
    • Agilent Technologies
    • MILabs BV
    • MR Solutions
    • Molecubes

第14章 附錄

  • 調查方法
  • 調查的先決條件
  • 首字母縮寫詞和縮寫詞
簡介目錄
Product Code: PMRREP34717

Persistence Market Research has recently released a comprehensive report on the global preclinical imaging market. This report provides an in-depth evaluation of essential market dynamics, including key drivers, trends, opportunities, and challenges, delivering detailed insights into the market structure.

Key Insights:

  • Preclinical Imaging Market Size (2024E): US$4.3 Bn
  • Projected Market Value (2031F): US$5.96 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 4.55%

Preclinical Imaging Market - Report Scope:

Preclinical imaging is pivotal in the development of new drugs and therapies, allowing researchers to visualize and understand the effects of interventions at an early stage. The preclinical imaging market encompasses a range of imaging technologies, including MRI, PET, CT, and optical imaging systems. These technologies are employed in various research settings, including academic institutions, pharmaceutical companies, and contract research organizations (CROs), to support drug development, disease research, and therapeutic efficacy studies.

Market growth is driven by the increasing demand for advanced imaging techniques in research, rising investments in drug discovery, and technological advancements that enhance imaging resolution and accuracy. Additionally, the growing prevalence of chronic diseases and the need for personalized medicine further propel market expansion.

Market Growth Drivers:

Several key factors are driving the global preclinical imaging market. The rapid evolution of imaging technologies, such as the integration of high-resolution MRI and PET/CT systems, is significantly enhancing research capabilities. Increased investment in R&D by pharmaceutical and biotechnology companies is fueling demand for sophisticated imaging solutions to accelerate drug development processes. Moreover, the rise in chronic diseases and the need for personalized medicine are driving the adoption of advanced imaging technologies for precise disease modeling and therapeutic assessments.

Technological innovations, including advancements in molecular imaging and the development of multimodal imaging systems, are also contributing to market growth. These innovations improve the accuracy of preclinical studies and enable more detailed analysis of biological processes, supporting the advancement of new treatments and therapies.

Market Restraints:

Despite promising growth prospects, the preclinical imaging market faces several challenges. The high cost associated with advanced imaging systems can limit their adoption, particularly among smaller research institutions and organizations in developing regions. Additionally, the complexity of imaging technologies and the need for specialized training can pose barriers to effective utilization. Regulatory constraints and the lengthy approval processes for new imaging technologies may also impact market dynamics.

Addressing these challenges requires ongoing efforts to reduce costs, enhance user training, and streamline regulatory pathways to facilitate broader access to advanced imaging solutions.

Market Opportunities:

The preclinical imaging market presents significant growth opportunities driven by technological advancements and increasing research activities. The development of portable and cost-effective imaging solutions, as well as the integration of AI and machine learning for data analysis, offers new avenues for market expansion. Furthermore, collaborations between research institutions, technology developers, and pharmaceutical companies are expected to drive innovation and accelerate the adoption of advanced imaging technologies.

The growing focus on personalized medicine and targeted therapies also opens up opportunities for the development of specialized imaging systems tailored to specific research needs. Strategic partnerships, investment in cutting-edge technologies, and expansion into emerging markets will be crucial for capitalizing on these opportunities and sustaining market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the preclinical imaging market globally?
  • Which imaging technologies and applications are gaining traction in preclinical research?
  • How are technological advancements reshaping the competitive landscape of the preclinical imaging market?
  • Who are the key players contributing to the preclinical imaging market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global preclinical imaging market?

Competitive Intelligence and Business Strategy:

Leading players in the global preclinical imaging market, including Siemens Healthineers, GE Healthcare, and Bruker Corporation, are focusing on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced imaging systems, such as high-resolution MRI and PET/CT scanners, and integrate cutting-edge technologies like AI for enhanced imaging capabilities. Collaborations with research institutions, pharmaceutical companies, and CROs facilitate market access and promote technology adoption. Emphasis on clinical research, evidence-based practices, and user training is essential for driving market growth and advancing preclinical imaging capabilities.

Key Companies Profiled:

  • Bruker Corporation
  • Siemens A.G.
  • General Electric (GE)
  • TriFoil Imaging
  • PerkinElmer, Inc.
  • VisualSonics Inc. (Fujifilm)
  • Mediso Ltd.
  • Agilent Technologies
  • MILabs B.V.
  • MR Solutions
  • Molecubes

Preclinical Imaging Market Research Segmentation

By Product Type

  • Imaging Systems
  • Reagents

By Application

  • Research and Development
  • Drug Discovery

By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic and research centres
  • Imaging Centres

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Preclinical Imaging Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Industry Developments and Key Market Events
  • 1.6. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Preclinical Imaging Market: Value Chain
    • 2.3.1. List of key players
    • 2.3.2. List of key distributors
  • 2.4. Forecast Factors - Relevance and Impact
  • 2.5. Covid-19 Impact Assessment
  • 2.6. PESTLE Analysis
  • 2.7. Porter Five Force's Analysis

3. Key Regulations/ Standards

4. Price Trend Analysis, 2019-2031

  • 4.1. Key Factors Impacting Prices
  • 4.2. Prices by Source

5. Global Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 5.1. Market Size (US$ Bn) Analysis and Forecast
    • 5.1.1. Historical Market Size Analysis, 2019-2023
    • 5.1.2. Current Market Size Forecast, 2024-2031
  • 5.2. Global Preclinical Imaging Market Outlook: Product Type
    • 5.2.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 5.2.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 5.2.2.1. Imaging Systems
        • 5.2.2.1.1. Optical Imaging Systems
        • 5.2.2.1.2. Nuclear Imaging Systems
        • 5.2.2.1.3. Micro MRI Systems
        • 5.2.2.1.4. Micro Ultrasound Systems
        • 5.2.2.1.5. Micro CT Systems
        • 5.2.2.1.6. Photoacoustic Imaging Systems
        • 5.2.2.1.7. Magnetic Particle Imaging Systems
      • 5.2.2.2. Reagents
        • 5.2.2.2.1. Preclinical Optical Imaging Reagents
        • 5.2.2.2.2. Preclinical Nuclear Imaging Reagents
        • 5.2.2.2.3. Preclinical MRI Contrast Agents
        • 5.2.2.2.4. Preclinical CT Contrast Agents
        • 5.2.2.2.5. Software
    • 5.2.3. Market Attractiveness Analysis: Product Type
  • 5.3. Global Preclinical Imaging Market Outlook: Application
    • 5.3.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
    • 5.3.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
      • 5.3.2.1. Research and Development
      • 5.3.2.2. Drug Discovery
    • 5.3.3. Market Attractiveness Analysis: Application
  • 5.4. Global Preclinical Imaging Market Outlook: End-user
    • 5.4.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
    • 5.4.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
      • 5.4.2.1. Pharmaceutical & Biotechnology Companies
      • 5.4.2.2. Academic and research centres
      • 5.4.2.3. Imaging Centres
      • 5.4.2.4. Other End-users
    • 5.4.3. Market Attractiveness Analysis: End-user

6. Global Preclinical Imaging Market Outlook: Region

  • 6.1. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
  • 6.2. Current Market Size (US$ Bn) Forecast By Region, 2024-2031
    • 6.2.1. North America
    • 6.2.2. Europe
    • 6.2.3. East Asia
    • 6.2.4. South Asia and Oceania
    • 6.2.5. Latin America
    • 6.2.6. Middle East & Africa
  • 6.3. Market Attractiveness Analysis: Region

7. North America Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 7.1.1. By Country
    • 7.1.2. By Product Type
    • 7.1.3. By Application
    • 7.1.4. By End-user
  • 7.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 7.2.1. U.S.
    • 7.2.2. Canada
  • 7.3. North America Preclinical Imaging Market Outlook: Product Type
    • 7.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 7.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 7.3.2.1. Imaging Systems
        • 7.3.2.1.1. Optical Imaging Systems
        • 7.3.2.1.2. Nuclear Imaging Systems
        • 7.3.2.1.3. Micro MRI Systems
        • 7.3.2.1.4. Micro Ultrasound Systems
        • 7.3.2.1.5. Micro CT Systems
        • 7.3.2.1.6. Photoacoustic Imaging Systems
        • 7.3.2.1.7. Magnetic Particle Imaging Systems
      • 7.3.2.2. Reagents
        • 7.3.2.2.1. Preclinical Optical Imaging Reagents
        • 7.3.2.2.2. Preclinical Nuclear Imaging Reagents
        • 7.3.2.2.3. Preclinical MRI Contrast Agents
        • 7.3.2.2.4. Preclinical CT Contrast Agents
        • 7.3.2.2.5. Software
  • 7.4. North America Preclinical Imaging Market Outlook: Application
    • 7.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
    • 7.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
      • 7.4.2.1. Research and Development
      • 7.4.2.2. Drug Discovery
  • 7.5. North America Preclinical Imaging Market Outlook: End-user
    • 7.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
    • 7.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
      • 7.5.2.1. Pharmaceutical & Biotechnology Companies
      • 7.5.2.2. Academic and research centres
      • 7.5.2.3. Imaging Centres
      • 7.5.2.4. Other End-users
  • 7.6. Market Attractiveness Analysis

8. Europe Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 8.1.1. By Country
    • 8.1.2. By Product Type
    • 8.1.3. By Application
    • 8.1.4. By End-user
  • 8.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 8.2.1. Germany
    • 8.2.2. France
    • 8.2.3. U.K.
    • 8.2.4. Italy
    • 8.2.5. Spain
    • 8.2.6. Russia
  • 8.3. Europe Preclinical Imaging Market Outlook: Product Type
    • 8.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 8.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 8.3.2.1. Imaging Systems
        • 8.3.2.1.1. Optical Imaging Systems
        • 8.3.2.1.2. Nuclear Imaging Systems
        • 8.3.2.1.3. Micro MRI Systems
        • 8.3.2.1.4. Micro Ultrasound Systems
        • 8.3.2.1.5. Micro CT Systems
        • 8.3.2.1.6. Photoacoustic Imaging Systems
        • 8.3.2.1.7. Magnetic Particle Imaging Systems
      • 8.3.2.2. Reagents
        • 8.3.2.2.1. Preclinical Optical Imaging Reagents
        • 8.3.2.2.2. Preclinical Nuclear Imaging Reagents
        • 8.3.2.2.3. Preclinical MRI Contrast Agents
        • 8.3.2.2.4. Preclinical CT Contrast Agents
        • 8.3.2.2.5. Software
  • 8.4. Europe Preclinical Imaging Market Outlook: Application
    • 8.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
    • 8.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
      • 8.4.2.1. Research and Development
      • 8.4.2.2. Drug Discovery
  • 8.5. Europe Preclinical Imaging Market Outlook: End-user
    • 8.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
    • 8.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
      • 8.5.2.1. Pharmaceutical & Biotechnology Companies
      • 8.5.2.2. Academic and research centres
      • 8.5.2.3. Imaging Centres
      • 8.5.2.4. Other End-users
  • 8.6. Market Attractiveness Analysis

9. East Asia Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 9.1.1. By Country
    • 9.1.2. By Product Type
    • 9.1.3. By Application
    • 9.1.4. By End-user
  • 9.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 9.2.1. China
    • 9.2.2. Japan
    • 9.2.3. South Korea
  • 9.3. East Asia Preclinical Imaging Market Outlook: Product Type
    • 9.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 9.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 9.3.2.1. Imaging Systems
        • 9.3.2.1.1. Optical Imaging Systems
        • 9.3.2.1.2. Nuclear Imaging Systems
        • 9.3.2.1.3. Micro MRI Systems
        • 9.3.2.1.4. Micro Ultrasound Systems
        • 9.3.2.1.5. Micro CT Systems
        • 9.3.2.1.6. Photoacoustic Imaging Systems
        • 9.3.2.1.7. Magnetic Particle Imaging Systems
      • 9.3.2.2. Reagents
        • 9.3.2.2.1. Preclinical Optical Imaging Reagents
        • 9.3.2.2.2. Preclinical Nuclear Imaging Reagents
        • 9.3.2.2.3. Preclinical MRI Contrast Agents
        • 9.3.2.2.4. Preclinical CT Contrast Agents
        • 9.3.2.2.5. Software
    • 9.3.3. Market Attractiveness Analysis: Product Type
  • 9.4. East Asia Preclinical Imaging Market Outlook: Application
    • 9.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
    • 9.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
      • 9.4.2.1. Research and Development
      • 9.4.2.2. Drug Discovery
    • 9.4.3. Market Attractiveness Analysis
  • 9.5. East Asia Preclinical Imaging Market Outlook: End-user
    • 9.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
    • 9.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
      • 9.5.2.1. Pharmaceutical & Biotechnology Companies
      • 9.5.2.2. Academic and research centres
      • 9.5.2.3. Imaging Centres
      • 9.5.2.4. Other End-users
    • 9.5.3. Market Attractiveness Analysis: End-user
  • 9.6. Market Attractiveness Analysis

10. South Asia & Oceania Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 10.1.1. By Country
    • 10.1.2. By Product Type
    • 10.1.3. By Source
    • 10.1.4. By Category
    • 10.1.5. By Distribution Channel
  • 10.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 10.2.1. India
    • 10.2.2. Southeast Asia
    • 10.2.3. ANZ
    • 10.2.4. Rest of South Asia & Oceania
  • 10.3. South Asia & Oceania Preclinical Imaging Market Outlook: Product Type
    • 10.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 10.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 10.3.2.1. Imaging Systems
        • 10.3.2.1.1. Optical Imaging Systems
        • 10.3.2.1.2. Nuclear Imaging Systems
        • 10.3.2.1.3. Micro MRI Systems
        • 10.3.2.1.4. Micro Ultrasound Systems
        • 10.3.2.1.5. Micro CT Systems
        • 10.3.2.1.6. Photoacoustic Imaging Systems
        • 10.3.2.1.7. Magnetic Particle Imaging Systems
      • 10.3.2.2. Reagents
        • 10.3.2.2.1. Preclinical Optical Imaging Reagents
        • 10.3.2.2.2. Preclinical Nuclear Imaging Reagents
        • 10.3.2.2.3. Preclinical MRI Contrast Agents
        • 10.3.2.2.4. Preclinical CT Contrast Agents
        • 10.3.2.2.5. Software
  • 10.4. South Asia & Oceania Preclinical Imaging Market Outlook: Application
    • 10.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
    • 10.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
      • 10.4.2.1. Research and Development
      • 10.4.2.2. Drug Discovery
  • 10.5. South Asia & Oceania Preclinical Imaging Market Outlook: End-user
    • 10.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
    • 10.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
      • 10.5.2.1. Pharmaceutical & Biotechnology Companies
      • 10.5.2.2. Academic and research centres
      • 10.5.2.3. Imaging Centres
      • 10.5.2.4. Other End-users
  • 10.6. Market Attractiveness Analysis

11. Latin America Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 11.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 11.1.1. By Country
    • 11.1.2. By Product Type
    • 11.1.3. By Application
    • 11.1.4. By End-user
  • 11.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 11.2.1. Brazil
    • 11.2.2. Mexico
  • 11.3. Latin America Preclinical Imaging Market Outlook: Product Type
    • 11.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 11.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 11.3.2.1. Imaging Systems
        • 11.3.2.1.1. Optical Imaging Systems
        • 11.3.2.1.2. Nuclear Imaging Systems
        • 11.3.2.1.3. Micro MRI Systems
        • 11.3.2.1.4. Micro Ultrasound Systems
        • 11.3.2.1.5. Micro CT Systems
        • 11.3.2.1.6. Photoacoustic Imaging Systems
        • 11.3.2.1.7. Magnetic Particle Imaging Systems
      • 11.3.2.2. Reagents
        • 11.3.2.2.1. Preclinical Optical Imaging Reagents
        • 11.3.2.2.2. Preclinical Nuclear Imaging Reagents
        • 11.3.2.2.3. Preclinical MRI Contrast Agents
        • 11.3.2.2.4. Preclinical CT Contrast Agents
        • 11.3.2.2.5. Software
  • 11.4. Latin America Preclinical Imaging Market Outlook: Application
    • 11.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
    • 11.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
      • 11.4.2.1. Research and Development
      • 11.4.2.2. Drug Discovery
  • 11.5. Latin America Preclinical Imaging Market Outlook: End-user
    • 11.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
    • 11.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
      • 11.5.2.1. Pharmaceutical & Biotechnology Companies
      • 11.5.2.2. Academic and research centres
      • 11.5.2.3. Imaging Centres
      • 11.5.2.4. Other End-users
  • 11.6. Market Attractiveness Analysis

12. Middle East & Africa Preclinical Imaging Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 12.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 12.1.1. By Country
    • 12.1.2. By Product Type
    • 12.1.3. By Application
    • 12.1.4. By End-user
  • 12.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 12.2.1. GCC
    • 12.2.2. South Africa
    • 12.2.3. Northern Africa
  • 12.3. Middle East & Africa Preclinical Imaging Market Outlook: Product Type
    • 12.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 12.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 12.3.2.1. Imaging Systems
        • 12.3.2.1.1. Optical Imaging Systems
        • 12.3.2.1.2. Nuclear Imaging Systems
        • 12.3.2.1.3. Micro MRI Systems
        • 12.3.2.1.4. Micro Ultrasound Systems
        • 12.3.2.1.5. Micro CT Systems
        • 12.3.2.1.6. Photoacoustic Imaging Systems
        • 12.3.2.1.7. Magnetic Particle Imaging Systems
      • 12.3.2.2. Reagents
        • 12.3.2.2.1. Preclinical Optical Imaging Reagents
        • 12.3.2.2.2. Preclinical Nuclear Imaging Reagents
        • 12.3.2.2.3. Preclinical MRI Contrast Agents
        • 12.3.2.2.4. Preclinical CT Contrast Agents
        • 12.3.2.2.5. Software
  • 12.4. Middle East & Africa Preclinical Imaging Market Outlook: Application
    • 12.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
    • 12.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
      • 12.4.2.1. Research and Development
      • 12.4.2.2. Drug Discovery
  • 12.5. Middle East & Africa Preclinical Imaging Market Outlook: End-user
    • 12.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
    • 12.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
      • 12.5.2.1. Pharmaceutical & Biotechnology Companies
      • 12.5.2.2. Academic and research centres
      • 12.5.2.3. Imaging Centres
      • 12.5.2.4. Other End-users
  • 12.6. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
    • 13.2.3. Tier Structure Analysis
    • 13.2.4. Regional Presence Analysis
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Bruker Corporation
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Products
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Siemens A.G.
    • 13.3.3. General Electric (GE)
    • 13.3.4. TriFoil Imaging
    • 13.3.5. PerkinElmer, Inc.
    • 13.3.6. VisualSonics Inc.(Fujifilm)
    • 13.3.7. Mediso Ltd.
    • 13.3.8. Agilent Technologies
    • 13.3.9. MILabs B.V.
    • 13.3.10. MR Solutions
    • 13.3.11. Molecubes

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations